Total Visits

Views
Subgroup analyses from an international, doubleblind, randomised, phase 3 trial evaluating the effect of denosumab on bone metastasis-free survival in men with castrate-resistant prostate cancer28

Select a period of time:

Views

Views
January 20250
February 20251
March 202515
April 20252
May 20252
June 20250
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States3
Spain1
Hong Kong1
 

Top cities views

Views
Council Bluffs1
Hong Kong1
Portage1